Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Angew Chem Int Ed Engl ; 61(23): e202202923, 2022 Jun 07.
Article in English | MEDLINE | ID: mdl-35313052

ABSTRACT

The existence of various surface active sites within a nanocrystal (NC) catalyst complicates understanding their respective catalytic properties and designing an optimal catalyst structure for a desired catalytic reaction. Here, we developed a novel approach that allows unequivocal investigation on the intrinsic catalytic reactivity of the edge and terrace atoms of NCs. Through the comparison of the catalytic behaviors of edge-covered Pd NCs, which were prepared by the selective deposition of catalytically inactive Au atoms onto the edge sites of rhombic dodecahedral (RD) Pd NCs, with those of the pristine RD Pd NCs toward alkyne hydrogenation and Suzuki-Miyaura coupling reactions, we could decouple the activity of the edge and {110}-plane atoms of the Pd NCs without uncertainties. We expect that this study will provide an opportunity to scrutinize the surface properties of various NC catalysts to a more precise level and devise ideal catalysts for intended catalytic reactions.

2.
Small ; 13(43)2017 11.
Article in English | MEDLINE | ID: mdl-28902979

ABSTRACT

Designing controlled hybrid nanoarchitectures between plasmonic and catalytic materials is of paramount importance to fully exploit each function of constituent materials. This study reports a new synthetic strategy for the realization of colloidal clusters of core-shell nanoparticles with plasmonic cores and catalytically active shells. The Au@M (M = Pd or Pt) nanoparticle clusters (NPCs) with a high density of sub-1 nm interparticle gaps are successfully prepared by the deposition of M shells onto thermally activated Au NPCs. NPCs with other metal, metal sulfide, and metal oxide shells can also be synthesized by using the present approach. The prepared Au@M NPCs show remarkably enhanced plasmonic performance compared to their Au@M nanoparticle counterparts due to the localization of a strong electromagnetic field at the interparticle gaps, while the inherent catalytic function of shells is intact. In situ real-time Raman spectroscopy and plasmon-enhanced electrocatalysis experiments demonstrate that the controlled assembly of core-shell nanoparticles is a very effective route for the synergistic integration of plasmonic and catalytic functions in a single platform.

3.
Org Biomol Chem ; 10(36): 7305-12, 2012 Sep 28.
Article in English | MEDLINE | ID: mdl-22850763

ABSTRACT

The remarkable catalytic effects of Fe(OTf)(3) in the context of the Pd(ii)-catalyzed conjugate addition of arylboronic acids to chromones were observed to yield a variety of flavanones under mild conditions. The addition of catalytic amounts of DDQ and KNO(2) to the reactions exclusively yielded flavone analogs. The reaction scope for the transformation was fairly broad, affording good yields of a wide range of flavanones and flavones, which are privileged structures in many biologically active compounds.


Subject(s)
Boronic Acids/chemistry , Chromones/chemistry , Flavanones/chemical synthesis , Flavones/chemical synthesis , Organometallic Compounds/chemistry , Palladium/chemistry , Catalysis , Flavanones/chemistry , Flavones/chemistry , Molecular Structure
5.
Cancer Lett ; 318(1): 68-75, 2012 May 01.
Article in English | MEDLINE | ID: mdl-22155744

ABSTRACT

Potentiation of anti-breast cancer activity of an imidazopyridine-based PI3Kα inhibitor, HS-104, was investigated in human breast cancer cells. HS-104 shows strong inhibitory activity against recombinant PI3Kα isoform and the PI3K signaling pathway, resulting in anti-proliferative activity in breast cancer cells. It also induced cell cycle arrest at the G(2)/M phase as well as apoptosis. Furthermore, oral administration of HS-104 significantly inhibited the growth of tumor in SkBr3 mouse xenograft models. Therefore, HS-104 could be considered as a potential candidate for the treatment of human breast cancer.


Subject(s)
Breast Neoplasms/drug therapy , Enzyme Inhibitors/pharmacology , Imidazoles/pharmacology , Phosphoinositide-3 Kinase Inhibitors , Pyridines/pharmacology , Animals , Apoptosis/drug effects , Blotting, Western , Breast Neoplasms/enzymology , Breast Neoplasms/pathology , Cell Cycle Checkpoints/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Fluorescent Antibody Technique , Humans , Immunoenzyme Techniques , Mice , Mice, Inbred BALB C , Mice, Nude , Phosphatidylinositol 3-Kinase/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...